linsidomine has been researched along with Compensatory Hyperinsulinemia in 1 studies
linsidomine: RN given refers to parent cpd; structure
Compensatory Hyperinsulinemia: A GLUCOSE-induced HYPERINSULINEMIA, a marker of insulin-resistant state. It is a mechanism to compensate for reduced sensitivity to insulin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moore, MC | 1 |
| Dicostanzo, CA | 1 |
| Smith, MS | 1 |
| Farmer, B | 1 |
| Rodewald, TD | 1 |
| Neal, DW | 1 |
| Williams, PE | 1 |
| Cherrington, AD | 1 |
1 other study available for linsidomine and Compensatory Hyperinsulinemia
| Article | Year |
|---|---|
Hepatic portal venous delivery of a nitric oxide synthase inhibitor enhances net hepatic glucose uptake.
Topics: Animals; Blood Glucose; Carbon; Catheterization; Dogs; Dose-Response Relationship, Drug; Enzyme Inhi | 2008 |